Dengue is one of the most widespread and fatal arboviral infections in the world. Early
detection of dengue virus (DENV) is essential to prevent the spread of the disease and …

Lipid nanoparticles (LNPs) can be designed to potentiate cancer immunotherapy by
promoting their uptake by antigen-presenting cells, stimulating the maturation of these cells …

More than a hundred thousand dengue cases are diagnosed in India annually, and about
half of the country's population carries dengue virus-specific antibodies. Dengue propagates …

Introduction Dengue is a worsening global public health problem. The vector-viral-host
interactions driving the pathogenesis of dengue are multi-dimensional. Sequential dengue …

Background India is hyperendemic to dengue and over 50% of adults are seropositive.
There is limited information on the association between neutralizing antibody profiles from …

DNA vaccines elicit antibody, T helper cell responses and CD8+ T cell responses. Currently,
little is known about the mechanism that DNA vaccines employ to induce adaptive immune …

Dengue is an infectious disease caused by dengue virus (DENV) and is a serious global
burden. Antibody-dependent enhancement and the ability of DENV to infect immune cells …

While most vaccines aim to develop a solid humoral and neutralizing antibody response
against the pathogen, an effective vaccine candidate should be able to stimulate both the B …

Dengue is the most prevalent mosquito-borne viral disease and continues to be a global
public health concern. Although a licensed dengue vaccine is available, its efficacy and …

Dengue is a predominant arboviral disease transmitted by Aedes (Stegomyia) aegypti and
Aedes (Stegomyia) albopictus mosquitoes, pose a significant global threat, contributing to …